From the Laboratory of Marine Biochemistry, We report here a novel type of ceramidase of
Pseudomonas aeruginosa AN17 isolated from the skin of a
patient with atopic dermatitis. The enzyme was purified 83,400-fold
with an overall yield of 21.1% from a culture supernatant of strain
AN17. After being stained with a silver staining solution, the purified
enzyme showed a single protein band, and its molecular mass was
estimated to be 70 kDa on SDS-polyacrylamide gel electrophoresis. The
enzyme showed quite wide specificity for various ceramides,
i.e. it hydrolyzed ceramides containing C12:0-C18:0 fatty
acids and 7-nitrobenz-2-oxa-1,3-diazole-labeled dodecanoic acid, and
not only ceramide containing sphingosine (d18:1) or sphinganine (d18:0)
but also phytosphingosine (t18:0) as the long-chain base. However, the
enzyme did not hydrolyze galactosylceramide, sulfatide, GM1, or
sphingomyelin, and thus was clearly distinguished from a
Pseudomonas sphingolipid ceramide N-deacylase
(Ito, M., Kurita, T., and Kita, K. (1995) J. Biol. Chem. 270, 24370-24374). This bacterial ceramidase had a pH
optimum of 8.0-9.0, an apparent Km of 139 µM, and a Vmax of 5.3 µmol/min/mg using N-palmitoylsphingosine as the
substrate. The enzyme appears to require Ca2+ for
expression of the activity. Interestingly, the 70-kDa protein catalyzed
a reversible reaction in which the N-acyl linkage of ceramide was either cleaved or synthesized. Our study demonstrated that
ceramidase is widely distributed from bacteria to mammals.
Ceramide is a common biosynthetic precursor of sphingolipids such
as acidic and neutral glycosphingolipids
(GSLs)1 and sphingomyelin
(SM). Recently, ceramide has emerged as a second messenger in cell
differentiation (1, 2) and apoptosis (3). In the epidermis of mammalian
skin, ceramide is produced from SM and glucosylceramide by the action
of sphingomyelinase and Ceramidase (CDase, EC 3.5.1.23) is an enzyme that hydrolyzes the
N-acyl linkage between fatty acids and sphingosine bases in
ceramides. It was strongly suggested that CDase plays a crucial role
not only in the control of cellular ceramide content but also in the
regulation of intracellular signal transduction (6-8). Since their
discovery by Gatt in rat brain (9, 10), CDases have been found
exclusively in mammals (11-13). Recently the gene of acidic CDase from
human urine was cloned and expressed in COS-1 cells (14). However, to
date, no CDase has been isolated from prokaryotes.
Although the etiologic factors in atopic dermatitis have yet to be
fully elucidated, dry and barrier-disrupted skin is a distinctive feature of this disease which could be evoked by a decrease of ceramide
in the stratum corneum (15). Recently, the activity of a SM-deacylase
capable of hydrolyzing SM to generate sphingosylphosphorylcholine and
fatty acid was detected in atopic dermatitis (16). The activity of this
enzyme was considered to relate to the decrease of ceramide in atopic
dermatitis (16), since the enzyme may decrease the content of SM which
appeared to be the main precursor of ceramide in the human skin.
However, a SM-deacylase was originally found in bacteria (17), and thus
we examined whether lesions of atopic dermatitis were infected with
sphingolipid-degrading bacteria. As a result, we have isolated many
sphingolipid-degrading bacteria including SM-deacylase producers from
the skin of patients with atopic dermatitis. Surprisingly, the most
dominant bacteria among isolates were the unknown CDase producers. This
report describes the purification and characterization of a novel type
of CDase of Pseudomonas aeruginosa AN17 isolated from the
skin of a patient with atopic dermatitis.
Materials--
14C-Labeled fatty acids (stearic
acid, palmitic acid, and lauric acid) were purchased from American
Radiolabeled Chemicals Inc. N-Palmitoylsphingosine, ceramide
III, SM, D-sphingosine, and Triton X-100 were purchased
from Sigma. A precoated Silica Gel 60 TLC plate was obtained from Merck
(Germany). Sep-Pak Plus Silica, Sep-Pak CM, Sep-Pak QMA, and Sep-Pak
C18 cartridges, and bicinchoninic acid protein assay kit were purchased
from Waters and Pierce, respectively. All other reagents were of the
highest purity available. A type strain of P. aeruginosa
IFO12689 was obtained from the Institute for Fermentation, Osaka (IFO),
Japan.
Patient--
AN17 was isolated from a 29-year-old female patient
with relatively severe atopic dermatitis, who was attending the
dermatologic clinic of our university and receiving no topical
corticosteroids. The patient was diagnosed according the clinical
criteria (18, 19), past history of other atopic disease, high total IgE
level (22,100 units/ml), and typical eczematous skin lesions on the face, neck, and extremities.
Isolation and Identification of AN17--
CDase-producing
bacteria were isolated from desquamated materials of the patient with
atopic dermatitis by an enrichment culture method using a synthetic
medium A (0.05% NH4Cl, 0.05%
K2HPO4, 0.5% NaCl, and 0.05% TDC, pH 7.2),
containing 0.05% SM as the sole source of carbon. When appropriate,
ceramide was used instead of SM at the same concentration. Briefly, a
small amount of desquamated material was suspended in 100 µl of
synthetic medium A containing 0.05% SM in an Eppendorf tube and
incubated at 30 °C for 3 days. After incubation, 5 µl of culture
were transferred to fresh medium and incubated at 30 °C for 3 days.
This procedure was repeated four or five times, and then SM-utilizing
bacteria were isolated using Trypto-Soya agar plates (Nissui Seiyaku
Co., Ltd., Japan) containing 0.01% SM. Each strain of isolated
bacteria was cultured in synthetic medium A containing 0.05% SM at
30 °C for 3 days, and the supernatant was then subjected to an assay
for CDase activity as described below. The identification of strain
AN17 was conducted according to the 8th edition of Bergy's
Manual of Determinative Bacteriology (20). The main
characteristics of AN17 were as follows: Gram-negative rod (0.8 × 1.6 µm), motile with polar flagella, optimum growth at 37 °C,
growth at 42 °C positive, O-F test oxidative, catalase positive,
oxidase positive, denitrification positive, fluorescent pigment
production positive, and GC content 66%. AN17 was thus assigned to
P. aeruginosa. This strain is maintained in a Trypto-Soya
agar slant containing 0.01% SM at our laboratory.
Preparation of 14C-Labeled Sphingolipids and
C12-NBD-Ceramide--
Syntheses of 14C-labeled ceramides
and GSLs were conducted by using the reverse hydrolysis (condensation)
reaction of sphingolipid ceramide N-deacylase (SCDase) as
described in Mitsutake et al. (21, 22). Interestingly,
SCDase efficiently condensed the free fatty acid to sphingosine,
although the enzyme hardly hydrolyzed ceramides (21). C12-NBD-ceramide
was also synthesized by
SCDase.2 Briefly,
N-TFAc-aminododecanoic acid, which was prepared from amino-fatty acid by blocking with TFAc, was condensed with sphingosine by SCDase at pH 10. After the reaction, excess amounts of sphingosine and N-TFAc-aminododecanoic acid were separated from
N-TFAc-amino-ceramide by using Sep-Pak C18, Sep-Pak Plus
Silica, and Sep-Pak QMA cartridges. The block was removed by
CH3ONa to produce CDase Assay--
The activity of CDase was measured using
C12-NBD-ceramide as a substrate as described below. The reaction
mixture contained 550 pmol of C12-NBD-ceramide and an appropriate
amount of the enzyme in 20 µl of 25 mM Tris-HCl, pH 8.5, containing 0.25% (w/v) Triton X-100 and 2.5 mM
CaCl2. Following incubation at 37 °C for 20 min, the
reaction was terminated by heating in a boiling water bath for 5 min.
The sample was evaporated, dissolved in 30 µl of chloroform/methanol
(2/1, v/v), and applied to a TLC plate, which was developed with
solvent I (chloroform, methanol, 25% ammonia, 90/20/0.5, v/v).
C12-NBD-fatty acid released by the action of the enzyme and the
remaining C12-NBD-ceramide were separated on a TLC and then analyzed
and quantified with a Shimadzu CS-9300 chromatoscanner (excitation 475 nm, emission 525 nm). One enzyme unit was defined as the amount capable
of catalyzing the release of 1 µmol of C12-NBD-fatty acid/min from
the C12-NBD-ceramide under the conditions described above. A value of
10 Department of Dermatology,
ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References
-glucosidase, respectively, and then
secreted into the extracellular space to form a mantle surrounding
individual horny (keratinized) cells (4). This extracellular ceramide,
arranged in a lamellar structure, may serve as a major component of the
permeability barrier and a skin water reservoir (5).
EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References
-amino-ceramide, which was then
purified with Sep-Pak C18 and Sep-Pak Plus Silica cartridges. Purified
-amino-ceramide was then labeled with NBD fluoride. C12-NBD-ceramide
was finally purified with a Sep-Pak Plus Silica cartridge.
3 units of enzyme was expressed as 1 milliunit in this
study.
Purification of CDase-- Inocula from an agar slant of the strain AN17 were introduced into a 14-ml test tube containing 4 ml of sterilized PY-medium (0.5% polypeptone, 0.1% yeast extract, 0.5% NaCl, pH 7.2) containing 0.01% SM and 0.05% TDC, and incubated at 30 °C for 1 day with vigorous shaking. The culture was then transferred to four cotton-plugged 2,000-ml flasks each containing 500 ml of the same medium and incubated at 30 °C for 2 days with vigorous shaking. The culture fluid was centrifuged at 5,600 × g for 20 min, and the supernatant obtained (1,900 ml) was then applied to a DEAE Sepharose FF column (30 × 120 mm; Amesham Pharmacia), previously equilibrated with 50 mM Tris-HCl, pH 7.5, containing 0.1% (w/v) Lubrol PX (buffer A), using a BPLC-600FC HPLC system (Yamazen Co., Japan). The enzyme was eluted from the column with a linear gradient of buffer A with increasing concentration of NaCl up to 1 M at a flow rate of 5 ml/min. The active fractions were pooled (36 ml), supplemented with NaCl to 1 M, and applied to a phenyl-Sepharose FF column (15 × 150 mm; Amersham) equilibrated with buffer A containing 1 M NaCl. The proteins were eluted with an increasing Lubrol PX gradient from 0 to 1% in buffer A, using a BPLC-600FC HPLC system at the flow rate of 5 ml/min. The active fractions were pooled (45 ml), and half of this sample was applied to a POROS PI packed column (4.6 × 100 mm; PerSeptive Biosystems, Inc.) equilibrated with buffer A. The enzyme was eluted with an increasing NaCl gradient from 0 to 1 M in buffer A, using the BioCAD system at the flow rate of 5 ml/min. The active fractions were pooled (15 ml) and concentrated using a Millipore Molcut LGC (10,000-cut), and an aliquot of the samples (0.25 ml) was applied to a TSKgel G3000SWXL column (7.8 × 300 mm; TOSOH Co., Japan) equilibrated with 50 mM phosphate buffer, pH 7.0, containing 0.1 M NaCl and 0.3% Lubrol PX. The protein was eluted from the column with the same buffer at a flow rate of 0.5 ml/min. The CDase activity was detected in Fr. 27-33 as shown in Fig. 1C. This chromatography using a TSKgel G3000SWXL column was found to be repeatable at least 20 times with high recovery.
Protein Assay and SDS-PAGE-- Protein content was determined by the bicinchoninic acid method (Pierce) or SDS-PAGE using bovine serum albumin as the standard. SDS-PAGE was carried out according to the method of Laemmli (23). The proteins on SDS-PAGE were visualized by staining with a silver-staining solution (24), and determined with a Shimadzu CS-9300 chromatoscanner with the reflectance mode set at 540 nm (Table I, Fig. 1C).
Measurement of Other Enzymes-- Exoglycosidases and proteases were assayed with p-nitrophenyl glycosides (25) and Azocoll (26), respectively, as the substrate. SCDase and endoglycoceramidase activities were determined using 14C-labeled GM1 (see structure of GM1 in Table II) as the substrate described in Mitsutake et al. (22). Sphingomyelinase activity was measured by the method described in Ito and Yamagata (27).
Determination of Digestion Products by HPLC, Gas Chromatography,
and FAB-MS--
Sphingosine bases were determined with HPLC
essentially as described in Merrill et al. (28). Briefly,
samples were dissolved in 50 µl of methanol and mixed with 50 µl of
the o-phthalaldehyde reaction buffer (9.9 ml of 3% boric
acid, pH 10.5, mixed with 0.1 ml of ethanol containing 5 mg of
o-phthalaldehyde and 5 µl of -mercaptoethanol). After
incubation at room temperature for 5 min, 0.25 ml of a mixture of
methanol and 5 mM potassium phosphate buffer, pH 7.0, (9/1,
v/v), was added. Sample was then applied to an Inertosil ODS-3 column
(4.6 × 100 mm; GL Science Inc.) which was equilibrated with the
same buffer solution. Sphingosine bases were eluted from the column at
a flow rate of 2.0 ml/min using HITACHI L-7100 HPLC system and detected
with a HITACHI L-7480 fluorescence detector (excitation 340 nm and
emission 455 nm). Gas chromatography of fatty acids was conducted with
GC-14A gas chromatography (Shimadzu Co., Japan) using a HR-SS-10 column
(30 m, Shinwa Chemical Industries, Ltd., Japan) with the temperature programmed from 150 to 220 °C at the rate of 4 °C/min. Before analyses, fatty acid standards or samples were heated at 80 °C for
2 h in 1 ml of 5% anhydrous HCl in methanol for methanolysis. Sphingosine and fatty acids were also analyzed by positive and negative
FAB-MS, respectively, using a Jeol JMS LX-2000 mass spectrometer (Jeol
Ltd., Japan). Triethanolamine and 3-nitrobenzylalcohol were used as the
matrix for the negative and positive ion mode, respectively.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Production and Purification of CDase of AN17 -- In this study, we have isolated many CDase-producing bacteria from desquamated materials of patients with atopic dermatitis using a synthetic medium containing SM or ceramide as the sole source of carbon. Among the isolates, the strain AN17, identified as P. aeruginosa, was selected for further study owing to its high productivity of CDase. The amount of CDase in the culture supernatant of AN17 was 1-2 milliunits/ml when the strain was cultivated at 30 °C for 2 days in a PY-medium containing SM. It was found that production of the CDase of this strain was induced by addition of ceramide or SM to the medium. Since the strain secreted sphingomyelinase as well, the SM added was hydrolyzed to generate ceramide which may induce the CDase production of this bacterium.
CDase was purified from 2 liters of culture supernatant of strain AN17 by sequential chromatographies on DEAE Sepharose FF, phenyl-Sepharose FF, POROS PI and TSKgel G3000SWXL as described under "Experimental Procedures." As shown in Table I, CDase was finally purified 83,400-fold with an overall yield of 21.1%. The most effective purification procedure for the bacterial CDase was the gel filtration chromatography using a TSKgel G3000SWXL column, in which the CDase was weakly adsorbed and eluted at about 1.5 bed volumes of the column. Using this chromatography, almost all remaining proteins were separated from the CDase, thereby increasing the purification about 600-fold (Table I). This chromatography seems to work as a kind of adsorption chromatography in which the enzyme may interact with the silica-based gel matrix. However, it should be noted that the chromatography using the TSKgel G3000SWXL column was specifically useful for bacterial alkaline CDase but not for other CDases, such as CDases of mouse liver (data not shown). This result may indicate that the bacterial CDase is somewhat different from other CDases in physical properties. The yield of CDase decreased with the progress of purification, but after phenyl-Sepharose chromatography it was found to increase (Table I), suggesting that some inhibitor(s) for CDase are removed at this step.
|
Purity and Molecular Mass of Bacterial CDase--
The final
preparation of bacterial CDase was completely free from the following
enzymes: - and
-galactosidases,
- and
-glucosidases,
-
and
-mannosidases,
-N-acetylhexosaminidase,
-N-acetylgalactosaminidase,
-N-acetylglucosaminidase,
-L-fucosidase,
proteases, sphingomyelinase, endoglycoceramidase, and SCDase, as was
confirmed by activity determination made using 0.1 milliunit of CDase
for each assay and incubation with an appropriate substrate for 16 h. The purified enzyme gave a single protein band on SDS-PAGE after
staining with a silver-staining solution under both reduced (Fig.
1A, land 1) and
nonreduced conditions (Fig. 1A, lane 2). The
apparent molecular mass of CDase was estimated to be 70 kDa on SDS-PAGE
under both conditions (Fig. 1B), indicating no subunit is
linked by disulfide bond in the enzyme molecule. This contrasts
completely with human urine acid CDase (13), which is composed of two
subunits of molecular mass of 13 kDa (
) and 40 kDa (
). The 70-kDa
protein was most likely to be a CDase, since the elution profile of
CDase activity on the chromatography using a TSKgel
G3000SWXL column at the final purification step coincided
exactly with that of 70-kDa band (Fig. 1C) and no other
co-eluted bands were observed.
|
Properties of Bacterial CDase--
The optimal activity of the
CDase was found around pH 8.5 using 25 mM Tris-HCl buffer
(Fig. 2A), indicating that
this enzyme should be classified as a type of alkaline CDase. The
enzyme was potently inhibited by Zn2+, Cu2+,
Hg2+, but not by Mn2+ or Mg2+ at 1 mM. EGTA and EDTA completely abolished the activity at the same concentration (Fig. 2B). After EDTA treatment,
Ca2+ addition reestablished the enzyme activity at 150% of
that before treatment, indicating that Ca2+ is the
preferred divalent cation. Mn2+ addition is about half as
effective as Ca2+ in reestablishing enzyme activity (Fig.
2B). It was found that sphingosine (d18:1), sphinganine
(d18:0), phytosphingosine (t18:0), and N-oleoylethanolamine
inhibited enzyme activity by 92.7, 84.2, 39.8, and 67.8%,
respectively, at a concentration of 100 µM. The addition
of Triton X-100 at a concentration of 0.25-0.5% (w/v) increased the
enzyme activity about 6-fold in comparison with that in the absence of
the detergent, while the enzyme activity was little affected by TDC or
cholate at a concentration up to 1% (w/v). The apparent
Km and the Vmax were
estimated to be 139 µM and 5.3 µmol/min/mg,
respectively, using N-palmitoylsphingosine as a substrate in
a 25 mM Tris-HCl, pH 8.5, containing 0.25% (w/v) Triton
X-100. The purified CDase was stable at room temperature (24 °C) for
12 h, but 25 and 100% of the activity were lost after being kept
at 37 °C for 12 h and at 60 °C for 5 min, respectively. The
enzyme can be kept at 85 °C for at least 2 months without detectable loss of activity in the presence of bovine serum albumin at
a final concentration of 1 mg/ml.
|
Action Mode of Bacterial CDase--
Ceramide from bovine brain
(ceramide III, Sigma) was digested with the enzyme and digestion
products were subjected to TLC which was visualized either with a
ninhydrin or a Coomassie Brilliant Blue reagent. A spot having the same
RF of the sphingosine standard (d18:1) was observed
on TLC after enzyme treatment (Fig. 3A, lanes 2 and
4). Fatty acids were also detected when TLC was visualized
with a Coomassie reagent (Fig. 3A, lane 2). Fig.
3B shows the chromatogram of HPLC showing sphingosine base
released from the authentic ceramide, N-palmitoylsphingosine
(C16:0, d18:1), by the enzyme. The product showed the same retention
time as sphingosine (d18:1). The fatty acid released from the ceramide
by the enzyme was identified to be palmitic acid (C16:0) by using gas
chromatography (Fig. 3C). Furthermore, the digestion
products of the ceramide showed molecular ion peaks at m/z
255 and 301, by FAB-MS with negative and positive ion modes,
respectively. These peaks coincided with (M H)
of
palmitic acid (C16:0) and (M + H)+ of sphingosine (d18:1),
respectively. These results clearly demonstrate that the enzyme cleaves
the N-acyl linkage of ceramide to produce sphingosine base
and fatty acid.
|
|
Specificity of Bacterial CDase-- The substrate specificity of CDase of AN17 was examined using various 14C-labeled sphingolipids. As shown in Table II, CDase hydrolyzed various species of ceramides but not GalCer, sulfatide, GM1, or SM. This result clearly shows that this bacterial CDase is completely different from the SCDase capable of hydrolyzing the N-acyl linkage between fatty acids and sphingosine bases in ceramides of various GSLs and SM (17). In contrast to CDase, SCDase hardly attacked the N-acyl linkage of ceramides (17). Ceramide containing sphingosine (d18:1), dihydrosphingosine (sphinganine, d18:0), or phytosphingosine (t18:0) was hydrolyzed by the bacterial CDase, but ceramide containing phytosphingosine was more resistant to hydrolysis by the enzyme (Table II). Interestingly, C12-NBD-ceramide (NBD-C12:0, d18:1) was hydrolyzed much faster than N-lauroylsphingosine (C12:0, d18:1), suggesting that the susceptibility of ceramide to an alkaline CDase increases with the attachment of NBD to the fatty acid moiety of ceramide.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The enzyme of P. aeruginosa strain AN17 seems to be a novel type of CDase, judging from the following observations. 1) The 70-kDa protein was the first purified CDase of prokaryotes. Previous reports on CDases were restricted to those from mammalian sources (11-13). 2) Mammalian CDases are classified mainly into two types according to their pH optima: an acidic CDase derived from lysosomes (13) and a membrane-bound alkaline enzyme (6, 7, 12). Since the bacterial CDase shows a pH optimum of 8.0-9.0, it should be classified as an alkaline enzyme. However, the enzyme was a secreted protein and not membrane-bound. 3) The molecular weight and secondary structure of bacterial CDase were clearly different from those of mammals (12, 13). The substrate specificity of the CDase of bacterial origin was not fully compared with that from other sources, because no detailed data for the purified enzyme is available at present except for the bacterial CDase. 4) The bacterial CDase is completely different from SCDase (17), since the CDase did not hydrolyze GSLs or SM. 5) The enzyme was activated by Ca2+ and inactivated by EDTA and EGTA. The activity of EDTA-inactivated enzyme was completely restored by addition of Ca2+, suggesting that Ca2+ affects the catalytic domain of the enzyme. All CDases reported so far were independent on metal ions including Ca2+.
It was suggested that an acidic ceramidase of rat brain participates in the synthesis as well as hydrolysis of ceramide (9, 10). However, the question of whether a single protein can catalyze both hydrolysis and synthesis reactions, or some other factors are required for ceramide synthesis by CDase remains open, because the enzyme has not yet been purified (9-11). In the present study, we clearly demonstrated that the 70-kDa protein can catalyze the reversible reactions in which the N-amide bond of ceramide was either cleaved or synthesized without the assistance of co-factors (Figs. 1C and 4).
In the skin of atopic dermatitis, decrease of ceramide content in the stratum corneum (15) and replacement of abnormal fatty acids in the ceramide moiety have been reported (29). These abnormalities might form the dry and barrier-disrupted skin. It was speculated by the present study that bacterial alkaline CDase could contribute directly or indirectly to the abnormality, since the enzyme was found to hydrolyze ceramides isolated from the desquamated materials of patients with atopic dermatitis (data not shown). The surface pH of normal skin is usually neutral or slightly acidic, whereas that of patients with atopic dermatitis tends to alkaline (30), which might suit the alkaline CDase of bacteria.
One significant finding in this study is that the CDase-producing bacterium AN17 was identified to be P. aeruginosa, which is a well known opportunistic pathogen (31). It is important to note that the strain P. aeruginosa IFO 12689 also retained the ability to produce CDase (data not shown). The role of the CDase as an etiologic factor in atopic dermatitis as well as infectious diseases caused by P. aeruginosa should be studied in the future.
Some bacterial sphingolipid-degrading enzymes have proved to be a useful tool for sphingolipid research (17, 27, 32, 33). This study shows it is possible to provide highly purified CDase in a large quantity which will facilitate the study of the structure and function of ceramide.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank H. Izu, Biotechnology Laboratories, Takara Shuzo Co., and K. Kita at our laboratory for their help in identification of bacteria and FAB-MS analysis, respectively. Thanks are also due to Dr. S. Hamanaka, Yamaguchi Rosai Hospital, for providing ceramide samples and helpful discussions. We are most grateful to Dr. T. Nakamura, Kyushu University, for encouragement and valuable suggestions throughout the course of this work.
![]() |
FOOTNOTES |
---|
* This work was supported in part by a Grant-in Aid for Scientific Research on Priority Area (09240101), a Grant-in Aid for Scientific Research (B) (09460051) from the Ministry of Education, Science and Culture of Japan, and the Yamada Science Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Dr. Makoto Ito, Laboratory of Marine Biochemistry, Faculty of Agriculture, Kyushu University, 6-10-1, Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan. Tel: 81-92-642-2900; Fax: 81-92-642-2900 or 81-92-642-2907; E-mail: makoto_i{at}agr.kyushu-u.ac.jp.
1 The abbreviations used are: GSL, glycosphingolipid; CDase, ceramidase; FAB-MS, fast atom bombardment-mass spectrometry; HPLC, high performance liquid chromatography; NBD, 7-nitrobenz-2-oxa-1,3-diazole; PAGE, polyacrylamide gel electrophoresis; SCDase, sphingolipid ceramide N-deacylase; SM, sphingomyelin; TDC, taurodeoxycholate; TFAc, trifluoroacetyl.
2 M. Tani, K. Kita, H. Komori, T. Nakagawa, and M. Ito, unpublished results.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|